Virginia House Bill HB902

Virginia 2024 Regular Session

• Introduced: 1/9/24
• Refer: 1/9/24

Caption

Health insurance; coverage for contraceptive drugs and devices.

Impact

With HB902, Virginia's insurance landscape will see significant changes, as this bill requires insurers to eliminate disparities in cost-sharing associated with contraceptive coverage. Notably, the legislation mandates that if an individual's healthcare provider determines a specific contraceptive due to medical necessity, insurers must cover that option without any cost-sharing, ensuring that patients are not penalized financially for necessary medical choices. This change is expected to improve healthcare outcomes by allowing greater access to contraceptive options.

Summary

House Bill 902 aims to enhance access to contraceptive drugs and devices by establishing mandatory coverage requirements for health insurance policies in Virginia. The bill stipulates that all insurers, corporations, and health maintenance organizations providing accident and sickness insurance must include coverage for any prescribed contraceptive drug or device approved by the FDA. This legislation seeks to ensure that individuals can obtain contraceptives with minimal out-of-pocket costs, thereby supporting reproductive health and personal agency in family planning decisions.

Contention

There may be points of contention surrounding HB902, particularly related to insurance providers adjusting to these new mandates. Supporters of the bill argue that eliminating cost barriers will improve access to essential healthcare services, while opponents could express concern over the potential rise in insurance premiums as companies adjust to the mandated coverage requirements. Some lawmakers may fear that such mandates could infringe upon the rights of employers who oppose contraception on moral or religious grounds, thereby igniting debate over personal freedoms versus reproductive health mandates.